Development of a Combined Heart and Carotid Artery Transplant Model to Investigate the Impact of Acute Rejection on Cardiac Allograft Vasculopathy

Journal of Heart and Lung Transplantation

Volumn 27, Issue 4, 2008, Pages 450-456

  Soleimani, Behzad ^a   Fu, Fumin ^b   Lake, Philip ^b   Shi, Victor C ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CAROTID ARTERY; CAROTID ARTERY TRANSPLANT; CLINICAL STUDY; CONTROLLED STUDY; HEART GRAFT; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; INTIMA; ISOGRAFT; LEUKOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ANIMALS; CAROTID ARTERIES; CORONARY DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY; HYPERPLASIA; MALE; MICE; MICE, INBRED STRAINS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; TUNICA INTIMA;

EID: 40949118938     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.01.015     Document Type: Article

References (24)

1. Billingham M.E. Graft coronary disease: the lesions and the patients. Transplant Proc 19 4 suppl 5 (1987) 19-25
2. Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Databasem. J Heart Lung Transplant 17 (1998) 744-753
3. Newby A.C., and Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. J Pathol 190 (2000) 300-309
4. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 340 (1999) 115-126
5. Arai S., Teramoto S., and Senoo Y. The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine. J Heart Lung Transplant 11 (1992) 757-762
6. Mennander A., Tiisala S., Paavonen T., Halttunen J., and Hayry P. Chronic rejection of rat aortic allograft. IIAdministration of cyclosporin induces accelerated allograft arteriosclerosis. Transpl Int 4 (1991) 173-179
7. Mehra M.R., Ventura H.O., Chambers R., et al. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol 26 (1995) 1537-1544
8. Russell P.S., Chase C.M., Winn H.J., and Colvin R.B. Coronary atherosclerosis in transplanted mouse hearts. ITime course and immunogenetic and immunopathological considerations. Am J Pathol 144 (1994) 260-274
9. Armstrong A.T., Strauch A.R., Starling R.C., Sedmak D.D., and Orosz C.G. Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation 63 (1997) 941-947
10. Tanaka M., Fedoseyeva E.V., and Robbins R.C. Graft coronary artery disease in murine cardiac allografts: proposal to meet the need for standardized assessment. J Heart Lung Transplant 24 (2005) 316-322
11. George J.F., Pinderski L.J., Litovsky S., and Kirklin J.K. Of mice and men: mouse models and the molecular mechanisms of post-transplant coronary artery disease. J Heart Lung Transplant 24 (2005) 2003-2014
12. Orosz C.G. Considerations regarding the contributions of B cells to chronic allograft rejection in experimental animal models. J Heart Lung Transplant 19 (2000) 634-637
13. Shi C., Russell M.E., Bianchi C., Newell J.B., and Haber E. Murine model of accelerated transplant arteriosclerosis. Circ Res 75 (1994) 199-207
14. Corry R.J., Winn H.J., and Russell P.S. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16 (1973) 343-350
15. Shi C., Lee W.S., He Q., et al. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A 93 (1996) 4051-4056
16. Ardehali A., Billingsley A., Laks H., Drinkwater Jr. D.C., Sorensen T.J., and Drake T.A. Experimental cardiac allograft vasculopathy in mice. J Heart Lung Transplant 12 (1993) 730-735
17. Kobashigawa J.A., Miller L., Yeung A., et al. Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound. Sandoz/CVIS Investigators. J Heart Lung Transplant 14 (1995) S221-S226
18. Jimenez J., Kapadia S.R., Yamani M.H., et al. Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study. J Heart Lung Transplant 20 (2001) 393-398
19. Stoica S.C., Cafferty F., Pauriah M., et al. The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. J Heart Lung Transplant 25 (2006) 420-425
20. Valantine H. Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial. J Heart Lung Transplant 24 4 suppl (2005) S191-S195 discussion S210-1
21. Krensky A.M., Weiss A., Crabtree G., Davis M.M., and Parham P. T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med 322 (1990) 510-517
22. Yin D., and Fathman C.G. CD4-positive suppressor cells block allotransplant rejection. J Immunol 154 (1995) 6339-6345
23. Lagaaij E.L., Hennemann I.P., Ruigrok M., et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 321 (1989) 701-705
24. Brunner-La Rocca H.P., Schneider J., Kunzli A., Turina M., and Kiowski W. Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease. Transplantation 65 (1998) 538-543